The aim of the study is to compare the efficacy and tolerance of autotitrating non-invasive ventilation (NIV) versus standard NIV in patients admitted to hospital with acute exacerbation of chronic respiratory failure. The investigators hypothesise that autotitrating NIV will ventilate patients with acute exacerbations of chronic respiratory failure as effectively as standard NIV.
The aim of the study is to compare the effect of two types of noninvasive ventilator (a small machine that assists breathing) in patients admitted to hospital with a sudden worsening of their existing breathing insufficiency, including an increase of carbon dioxide in the blood (hypercapnia) and acidity of the blood. Noninvasive ventilation (NIV) is standard therapy for patients with acute hypercapnic exacerbations (sudden worsening of existing breathing insufficiency) of both chronic obstructive pulmonary disease (COPD) and nonCOPD patients. The most common type of NIV is bilevel pressure support which assists patient breathing by delivering different levels of air pressure during inspiration and expiration via a mask covering the nose or nose and mouth. Standard bilevel NIV (VPAP™) has been further developed to create a new automatically adjusting NIV (AutoVPAP™). Automatically adjusting NIV varies the inspiratory air pressure according to the airflow rates generated by the patient. This may improve patient comfort, hours of NIV use and recovery time. Patients over the age of 18 admitted to Royal Brompton Hospital respiratory ward will be considered for entry into this randomised crossover study. If eligible for inclusion and willing to take part patients will be setup on automatically adjusting NIV or standard NIV, assigned in random order. After 24 hours on the first NIV the patient will be swapped to the alternative NIV for a further 24 hours of treatment.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Automatically titrated non-invasive ventilator, with target gross alveolar ventilation, end expiratory positive pressure, and back up respiratory rate determined by the clinician based on height and weight. The NIV must be used for as many hours as possible over the 24 hour period but breaks for meals, physiotherapy and bathroom are allowed.
Standard non-invasive ventilator, with inspiratory and expiratory positive pressure determined by the healthcare professional. The NIV must be used for as many hours as possible over the 24 hour period but breaks for meals, physiotherapy and bathroom are allowed.
Royal Brompton Hospital
London, United Kingdom
pH at 1+ hour
pH of arterial blood after 1 hour of treatment with non-invasive ventialtion compared baseline value
Time frame: 1 hour
pH at 4+ hours
pH of arterial blood after 4 hours of treatment with non-invasive ventialtion compared to baseline value
Time frame: 4+ hours of NIV treatment
Respiratory Rate at 1+ hour
Respiratory rate after 1 hour of treatment with non-invasive ventilation compared to baseline value
Time frame: 1+ hour of NIV treatment
Respiratory rate at 4+ hours
Respiratory rate after 4 hours of treatment with non-invasive ventilation compared to baseline value
Time frame: 4+ hours of NIV treatment
overnight mean transcutaneous carbon dioxide
mean overnight transcutaneous carbon dioxide during sleep period
Time frame: 24 hours
PaCO2 at 1+ hours
Carbon dixoide level of arterial blood after 1 hour of treatment with non-invasive ventilation compared to baseline
Time frame: 1+ hours of NIV treatment
PaCO2 at 4+ hours
Carbon dioxide level in arterial blood after 4 hours of treatment with non-invasive ventilation compared to baseline value
Time frame: 4+ hours of NIV treatment
PaO2 at 1+ hour
Oxygen level in arterial blood after 1 hour of treatment with non-invasive ventilation compared to baseline value
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 1+ hour of NIV treatment
PaO2 at 4+ hours
Oxygen level in arterial blood after 4+ hours of treatment with non-invasive ventilation compared to baseline value
Time frame: 4+ hours of NIV treatment